SWKH earnings

Acquisition of high-quality portfolio centered on healthcare and life sciences investments Accelerates strategy to diversify and optimize portfolio while adding significant scale Enhances financial profile and is expected to be accretive to net investment income ("NII") MENLO PARK, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (NASDAQ:RWAY) ("Runway Growth" or the "Company"), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it has entered into a definitive merger agreement to acquire SWK Holdings Corporation (NASDAQ:SWKH) ("SWK"), a life science focused specialty fi

Conference Call Scheduled for Friday, November 15, 2024, at 09:00 a.m. CSTCorporate HighlightsThird quarter 2024 GAAP net income was $3.5 million, compared with GAAP net income of $4.5 million for the third quarter 2023.Third quarter 2024 finance receivables segment adjusted non-GAAP net income was $5.0 million, compared with adjusted non-GAAP net income of $5.8 million for the third quarter 2023.As of September 30, 2024, net finance receivables were $255.9 million, a 14.4% increase from September 30, 2023.The third quarter 2024 effective yield was 14.6%, a 60 basis points increase from third quarter 2023.As of September 30, 2024, GAAP book value per share was $22.94, a 3.7% increase from $2

Company Announces Q3 Earnings and Conference Call Dates DALLAS, TX / ACCESSWIRE / October 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, provided today a portfolio update and announced the anticipated date of the third quarter earnings and conference call schedule.The Company intends to issue their third quarter financials after market close on November 14, 2024, and will host a conference call at 9:00 a.m. Central Time on November 15, 2024, to discuss the company's financial results for the quarter. Call details will be available in the quarterly results

DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies."During the second quarter we advanced capital to two existing borrowers and are working towards an additional closing in the next month," said SWK President and CEO Jody Staggs."Importantly, several of our borrower partners took advantage of the strong capital markets to raise equity or other forms of non-dilutive financing. We also repurchased $1 million of st

Conference Call and Live Audio Webcast Scheduled for Thursday, May 16, 2024, at 10:00 a.m. ET Corporate HighlightsFirst quarter 2024 GAAP net income was $0.9 million, compared with net income of $4.6 million or $0.36 per share, for the first quarter 2023First quarter 2024 finance receivables segment adjusted non-GAAP net income was $2.7 million, compared with adjusted non-GAAP net income of $7.3 million for the first quarter 2023As of March 31, 2024, gross finance receivables were $274.5 million, a 10.3% increase from March 31, 2023As of March 31, 2024, book value per share was $22.46As of March 31, 2024, non-GAAP tangible financing book value per share was $19.69First quarter 2024 finance p

Conference Call and Live Audio Webcast Scheduled for Wednesday, August 9, 2023, at 5:00 p.m. ET Corporate Highlights Second quarter 2023 GAAP net income was $3.9 million or $0.31 per diluted share, compared with net income of $0.6 million or $0.04 per diluted share, for the second quarter 2022Closed a $45.0 million credit facility with First Horizon BankYear-to-date Enteris has booked $2.0 million of CDMO projects and has $9.0 million of CDMO proposals outstanding, which is expected to drive revenue growth in 2H23During the quarter SWK repurchased 272,492 shares of common stock for a total cost of $4.6 million, or $16.88 per share; Year-to-date through August 5, 2023, SWK has repurchased 327

Conference Call and Live Audio Webcast Scheduled for Wednesday, August 9, 2023, at 5:00 p.m. ET DALLAS, Aug. 8, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced today that the Company will host a conference call and live audio webcast on Wednesday, August 9, 2023, at 5:00 p.m. ET, to discuss its corporate and financial results for the second quarter of 2023. Interested participants and investors may access the conference c

Conference Call and Live Audio Webcast Scheduled for Thursday, May 11, 2023, at 10:00 a.m. ET Corporate Highlights First quarter 2023 GAAP net income was $4.6 million or $0.36 per diluted share, compared with net income of $3.5 million or $0.27 per share, for the first quarter 2022Enteris has bid on approximately $7.0 million of CDMO projects year-to-date which is expected to drive revenue growth in 2H23Enteris first quarter 2023 operation expenses declined 45% compared with the fourth quarter 2022Michael Miner joined SWK as Vice President of Investments and Peter Blumberg joined as Vice President of Business DevelopmentSWK repurchased 28,766 shares of common stock during the quarter for a t

Conference Call and Live Audio Webcast Scheduled for Today, April 3, 2023, at 10:00 a.m. ET Corporate Highlights Jody Staggs named President and Chief Executive OfficerAppointed Laurie Dotter as Chair of the Board and Jerry Albright to the Board of DirectorsRestructuring at Enteris with quarterly operating expenses expected to decline by over $1.0 million per quarter by third quarter 2023Repurchased 29,438 shares of common stock during the quarter for a total cost of $0.5 million and YTD 2023 have purchased an additional 27,291 shares of common stock for a total cost of $0.5 millionFinance Receivables Segment Update Fourth quarter 2022 GAAP net income was $2.8 million, compared with net inco

Conference Call and Live Audio Webcast Scheduled for Monday, April 3, 2023, at 10:00 a.m. ET DALLAS, March 31, 2023 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced today that the Company will host a conference call and live audio webcast on Monday, April 3, 2023, at 10:00 a.m. ET, to discuss its corporate and financial results for the fourth quarter and full year of 2022. Interested participants and investors may access the co

Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET Corporate Highlights Successful leadership transition with Jody Staggs named President and Interim Chief Executive Officer and Yvette Heinrichson named Chief Financial OfficerClosed three new transactions during the quarter, totaling $57.5 million of committed capitalSubsidiary Enteris achieved $5.0 million milestone with Cara Therapeutics; SWK will retain $2.5 millionRepurchased 34,463 shares of common stock during the quarter for a total cost of $0.6 millionThird quarter 2022 GAAP net income was $6.6 million or $0.51 per diluted shareFinance Receivables Segment Update Third quarter 2022 GAAP

Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET DALLAS, Nov. 8, 2022 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced today that the Company will host a conference call and live audio webcast on Thursday, November 10, 2022, at 10:00 a.m. ET, to discuss its corporate and financial results for the third quarter 2022. Interested participants and investors may access the conference call by dialing either: (844) 378-6488 (U.S.)(412) 317-1079 (International)Passcode: 10172367An audio webcast will b

Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET Corporate Highlights Celebrated 10th anniversary as a life science focused specialty finance company catering to small- and mid-sized commercial-stage companiesAdded to Russell 3000® Index, Russell 2000® Index and Russell Microcap® IndexDuring the second quarter of 2022, $2.6 million was funded to existing borrowersSubsequent to quarter end, closed a new transaction, deploying $5.0 millionSWK well positioned for current capital markets environment with cash and unfunded credit facility availability totaling $77.1 million as of June 30, 2022Finance Receivables Segment Update For the three months e

Conference Call and Live Audio Webcast Scheduled for Thursday, August 11, 2022, at 10:00 a.m. ET DALLAS, Aug. 9, 2022 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced today that the Company will host a conference call and live audio webcast on Thursday, August 11, 2022, at 10:00 a.m. ET, to discuss its corporate and financial results for the second quarter 2022. Interested participants and investors may access the conference call by dialing either: (844) 378-6488 (U.S.)(412) 317-1079 (International)Passcode: 10169701An audio webcast will be a

Conference Call and Live Audio Webcast Scheduled for Wednesday, May 11, 2022, at 10:00 a.m. ET Corporate Highlights During first quarter of 2022, completed two structured debt transactions deploying $18.5 million with an additional $4.2 million funded to existing borrowersReceived a $10.7 million cash payment from B&D Dental to successfully resolve long-running non-accrual position. Loan carried at $8.3 million with gain recognized during the quarterFirst quarter 2022 GAAP net income grew 2.9% to $3.5 million compared to the first quarter 2021SWK well positioned for current capital markets environment with cash and unfunded credit facility availability totaling $63.4 million as of March 31,

Conference Call and Live Audio Webcast Scheduled for Wednesday, May 11, 2022, at 10:00 a.m. ET DALLAS, May 10, 2022 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, announced today that the Company will host a conference call and live audio webcast on Wednesday, May 11, 2022, at 10:00 a.m. ET, to discuss its corporate and financial results for the first quarter 2022. Interested participants and investors may access the conference call by dialing either: (844) 378-6488 (U.S.)(412) 317-1079 (international)Passcode: 10166330An audio webcast will be access

Conference Call and Live Audio Webcast Scheduled for Monday, March 28, 2022, at 10:00 a.m. ET Corporate Highlights Reconstituted Board and appointed Wendy DiCicco, Robert K. Hatcher, and Laurie Dotter as independent directorsCompleted four transactions from December 2021 through March 2022, deploying $38.5 millionReceived a $10.7 million cash payment from B&D Dental to successfully resolve long-running non-accrual position. Loan carried at $8.3 millionIn December 2021, subsidiary Enteris received a $5.0 million milestone payment from Cara Therapeutics with SWK retaining $3.0 millionEnteris currently advancing six partner feasibility studiesFinance Receivables Segment Update As of December 31

DALLAS, Nov. 12, 2021 /PRNewswire/ -- Corporate Updates Conclusion of strategic review process with SWK to focus on specialty finance receivables business SWK evaluating ongoing dividend and additional leverageThird Quarter 2021 Finance Receivables Segment Updates: As of September 30, 2021, tangible book value per share was $17.50, a 12.7% increase from September 30, 2020 For the third quarter 2021, finance portfolio effective yield was 13.8%, a 40-bps increase compared with 13.4% for the third quarter 2020 For the third quarter 2021, finance portfolio realized yield was 18.8%, compared to 17.4% for the third quarter 2020 Core finance receivables business generated adjusted non-GAAP n

DALLAS, Aug. 16, 2021 /PRNewswire/ --  Corporate Updates The Specialty Finance Receivables and Pharmaceutical Development segments each reported strong quarters Closed a $5.0 million synthetic royalty transaction in April 2021 and a $9.5 million secured loan financing in July 2021 In June 2021, Enteris earned a $10.0 million milestone payment from Cara Therapeutics, with Enteris retaining $3.9 million Year-to-date, Enteris has signed three new partner feasibility studies Board of Directors authorized a $5.0 million share repurchase program SWK announced formation of Strategic Review CommitteeSecond Quarter 2021 Finance Receivables Segment Updates: As of June 30, 2021, tangible book value pe

DALLAS, July 19, 2021 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage companies, today provided an update on the achievements of its portfolio and partner companies during the first half of 2021. "We are pleased with the latest additions to our royalty and debt portfolio, as well as the advances reported by our partner companies over the past several months," stated Winston Black, Chairman and CEO of SWK. "Collectively, life sciences companies are making a strong recovery from the disruption and supply chain issues that temporarily impacted the industry last yea

DALLAS, May 17, 2021 /PRNewswire/ -- Corporate Updates YTD SWK has closed two financings totaling up to $14.0 million Enteris BioPharma subsidiary announced completion of manufacturing facility expansion and launch of CDMO business SWK to form a strategic review committee to identify, review and explore strategic alternatives to maximize stockholder value Marcus Pennington named to Board of Directors First Quarter 2021 Finance Receivables Segment Updates: As of March 31, 2021, tangible book value per share was $16.31, a 10.6% increase from March 31, 2020 For the first quarter 2021, finance portfolio effective yield was 13.8%, a 40-bps increase compared with 13.4% for the first quarter 2020 F

DALLAS, March 31, 2021 /PRNewswire/ -- Corporate Highlights Closed four transactions in 2020 deploying $34.8 million; additional $8.1 million deployed to existing borrowers Income producing assets as of December 31, 2020 reached an all-time high of $206.0 million, accompanied by strong credit trends Closed a $9.0 million transaction in March 2021, deploying $7.1 million Received two milestone payments from Cara Therapeutics totaling $5.0 million, with SWK retaining $3.0 million and the other $2.0 million being remitted to Enteris' prior owner.  Specialty Finance Segment Highlights: For the fourth quarter of 2020, finance portfolio realized yield was 16.6%, compared to 20.4% for the f